+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Automated Autoinjectors Market by Design, by Usage, by Application, and by End-User: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

  • ID: 4853978
  • Report
  • February 2019
  • Region: Global
  • 110 pages
  • Zion Market Research

The report covers a forecast and an analysis of the automated autoinjectors market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the automated autoinjectors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the automated autoinjectors market on a global level.

In order to give the users of this report a comprehensive view of the automated autoinjectors market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the automated autoinjectors market by segmenting the market based on design, usage, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries.

Some leading players of the global automated autoinjectors market include Unilife Corporation, Becton, Dickinson & Co., Biogen Idec, Pfizer, Inc., Mylan N.V., Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, AbbVie, and Scandinavian Health Ltd.

This report segments the global automated autoinjectors market into:

Global Automated Autoinjectors Market: Design Analysis

  • Customized Autoinjector
  • Standardized Autoinjector

Global Automated Autoinjectors Market: Usage Analysis

  • Reusable Autoinjector
  • Disposable Autoinjector

Global Automated Autoinjectors Market: Application Analysis

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Others

Global Automated Autoinjectors Market: End-User Analysis

  • Hospitals and Clinics
  • Home Care Settings

Global Automated Autoinjectors Market: Regional Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global automated autoinjectors market, 2016-2025 (USD Billion)
    • 2.2. Global automated autoinjectors market: snapshot
  • Chapter 3. Automated Autoinjectors Market - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global automated autoinjectors market drivers: impact analysis
      • 3.2.2. The growing prevalence of targeted therapies
      • 3.2.3. Favorable reimbursements and government support
      • 3.2.4. An increasing number of regulatory approvals
      • 3.2.5. Availability of generic versions of autoinjectors
      • 3.2.6. Technological advancements and design developments
    • 3.3. Market Restraints
      • 3.3.1. Global automated autoinjectors market restraints: impact analysis
      • 3.3.2. Preference for alternative drug delivery modes
      • 3.3.3. High product prices restrict patients in emerging economies from purchasing auto-injectors
    • 3.4. Opportunities
      • 3.4.1. Patent expiry of biologics to drive the demand for biosimilars
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by design
      • 3.6.2. Market attractiveness analysis, by usage
      • 3.6.3. Market attractiveness analysis, by application
      • 3.6.4. Market attractiveness analysis, by end-user
      • 3.6.5. Market attractiveness analysis, by region
  • Chapter 4. Global Automated Autoinjectors Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global automated autoinjectors market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Automated Autoinjectors Market - Design Analysis
    • 5.1. Global automated autoinjectors market: design overview
      • 5.1.1. Global automated autoinjectors market revenue share, by design, 2018 and 2025
    • 5.2. Customized Autoinjector
      • 5.2.1. Global automated autoinjectors market for customized autoinjector,2016-2025 (USD Billion)
    • 5.3. Standardized Autoinjector
      • 5.3.1. Global automated autoinjectors market for standardized autoinjector,2016-2025 (USD Billion)
  • Chapter 6. Global Automated Autoinjectors Market - Usage Analysis
    • 6.1. Global automated autoinjectors market: usage overview
      • 6.1.1. Global automated autoinjectors market revenue share, by usage, 2018 and 2025
    • 6.2. Reusable Autoinjector
      • 6.2.1. Global automated autoinjectors market for reusable autoinjector, 2016-2025 (USD Billion)
    • 6.3. Disposable Autoinjector
      • 6.3.1. Global automated autoinjectors market for disposable autoinjector, 2016-2025 (USD Billion)
  • Chapter 7. Global Automated Autoinjectors Market - Application Analysis
    • 7.1. Global automated autoinjectors market: application overview
      • 7.1.1. Global automated autoinjectors market revenue share, by application, 2018 and 2025
    • 7.2. Anaphylaxis
      • 7.2.1. Global automated autoinjectors market for anaphylaxis,2016-2025 (USD Billion)
    • 7.3. Rheumatoid Arthritis
      • 7.3.1. Global automated autoinjectors market for rheumatoid arthritis,2016-2025 (USD Billion)
    • 7.4. Multiple Sclerosis
      • 7.4.1. Global automated autoinjectors market for multiple sclerosis,2016-2025 (USD Billion)
    • 7.5. Diabetes
      • 7.5.1. Global automated autoinjectors market for diabetes,2016-2025 (USD Billion)
    • 7.6. Others
      • 7.6.1. Global automated autoinjectors market for others,2016-2025 (USD Billion)
  • Chapter 8. Global Automated Autoinjectors Market - End-User Analysis
    • 8.1. Global automated autoinjectors market: end-user overview
      • 8.1.1. Global automated autoinjectors market revenue share, by end-user, 2018 and 2025
    • 8.2. Hospitals and clinics
      • 8.2.1. Global automated autoinjectors market for hospitals and clinics,2016-2025 (USD Billion)
    • 8.3. Home Care Settings
      • 8.3.1. Global automated autoinjectors market for home care settings,2016-2025 (USD Billion)
  • Chapter 9. Global Automated Autoinjectors Market - Regional Analysis
    • 9.1. Global automated autoinjectors market: regional overview
      • 9.1.1. Global automated autoinjectors market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
      • 9.2.2. North America automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
      • 9.2.3. North America automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
      • 9.2.4. North America automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.2.5. The U.S.
        • 9.2.5.1. The U.S. automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.2.5.2. The U.S. automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.2.5.3. The U.S. automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.2.5.4. The U.S. automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.2.6. Canada
        • 9.2.6.1. Canada automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.2.6.2. Canada automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.2.6.3. Canada automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.2.6.4. Canada automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
      • 9.3.2. Europe automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
      • 9.3.3. Europe automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.4. Europe automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.5. UK
        • 9.3.5.1. UK automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.3.5.2. UK automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.3.5.3. UK automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.5.4. UK automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.6. Germany
        • 9.3.6.1. Germany automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.3.6.2. Germany automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.3.6.3. Germany automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.6.4. Germany automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.3.7.2. France automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.3.7.3. France automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.7.4. France automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.3.8.2. Rest of Europe automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.3.8.3. Rest of Europe automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.3.8.4. Rest of Europe automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.5. China
        • 9.4.5.1. China automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.4.5.2. China automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.4.5.3. China automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.5.4. China automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.6. Japan
        • 9.4.6.1. Japan automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.4.6.2. Japan automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.4.6.3. Japan automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.6.4. Japan automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.7. India
        • 9.4.7.1. India automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.4.7.2. India automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.4.7.3. India automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.7.4. India automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.4.8.2. Rest of Asia Pacific automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.4.8.3. Rest of Asia Pacific automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.4.8.4. Rest of Asia Pacific automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
      • 9.5.2. Latin America automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
      • 9.5.3. Latin America automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
      • 9.5.4. Latin America automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.5.5.2. Brazil automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.5.5.3. Brazil automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.5.5.4. Brazil automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
        • 9.5.6.2. Rest of Latin America automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
        • 9.5.6.3. Rest of Latin America automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
        • 9.5.6.4. Rest of Latin America automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa automated autoinjectors market revenue, by design, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa automated autoinjectors market revenue, by usage, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa automated autoinjectors market revenue, by application, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa automated autoinjectors market revenue, by end-user, 2016-2025 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1. Unilife Corporation
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Becton, Dickinson & Co.
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Biogen Idec
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Pfizer, Inc.
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Mylan N.V.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Sanofi
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Owen Mumford
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Teva Pharmaceutical
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Amgen
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Ypsomed
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. Abbvie
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments
    • 10.12. Scandinavian Health Ltd.
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product portfolio
      • 10.12.4. Business strategy
      • 10.12.5. Recent developments
Note: Product cover images may vary from those shown
Adroll
adroll